JamBot Logo
1-100 of about 147 matches for site:www.patentsencyclopedia.com site:www.patentsencyclopedia.com including lysine
https://www.patentsencyclopedia.com/app/20220296509
ORAL COMPOSITION INCLUDING GELS - Patent application Inventors list Assignees list Classification tree browser Top 100 Inventors Top 100 Assignees
https://www.patentsencyclopedia.com/app/20220232873
higher, e.g., 0.3 V or higher, including 0.5 volts or higher, and including 1.0 volts or
https://www.patentsencyclopedia.com/app/20220296547
to slow, diminish, or reverse signs of aging. Additionally, lysine analogs or therapeutic agents including lysine analogs could be
https://www.patentsencyclopedia.com/hgl/09-22-22/09-22-22_9
2022-09-22 20220296501 ORAL COMPOSITION WITH POLYMERIC COMPONENT - The disclosure provides oral compositions including at least one active
https://www.patentsencyclopedia.com/app/20220233487
amino acid is at least one selected from the group consisting of lysine, arginine and ornithine
https://www.patentsencyclopedia.com/app/20220232855
applications. [0004] Unfortunately, not all amino acids withstand the ethanol production process equally well. Lysine, in particular
https://www.patentsencyclopedia.com/app/20220235274
fatty binder, shaped by compression. Use of derivatives of basic amino acids, including lysine, have been proposed
https://www.patentsencyclopedia.com/app/20130023059
from the twenty kinds of amino acids consisting of cysteine, Lysine, Histidine, Phenylalanine, Tyrosine, Glycine
https://www.patentsencyclopedia.com/app/20220281957
from the group consisting of: arginine, asparagine, aspartate, glycine, histidine, isoleucine, leucine, lysine, methionine, phenylalanine, proline, serine
https://www.patentsencyclopedia.com/app/20220280599
CII peptides with unmodified lysine residues and CII peptides with the first lysine being galactosyl-hydroxylysine; (e
https://www.patentsencyclopedia.com/app/20220280656
and methods for treating SCD. SUMMARY OF THE INVENTION [0007] Compositions including peptide nucleic acid (PNA
https://www.patentsencyclopedia.com/app/20220280935
wherein the first coating layer includes one or more of Poly-1-lysine, 3-Aminopropyltriethoxysilane, or (3
https://www.patentsencyclopedia.com/app/20220282258
a branched histidine-lysine co-polymer. For example, the branched histidine-lysine polymer may have the
https://www.patentsencyclopedia.com/app/20220280426
form a dextrose/lysine solution. At a step 108, the dextrose/lysine solution is filtered through
https://www.patentsencyclopedia.com/app/20220280627
name: Publication date: 2022-09-08 Patent application number: 20220280627 Abstract: Provided is an immunogenic composition including a peptide
https://www.patentsencyclopedia.com/app/20220298450
the method according to the present invention also involves steps, such as also including a subsequent
https://www.patentsencyclopedia.com/app/20220233674
The conjugate of claim 1 wherein the conjugate has a lysine consumption of 3
https://www.patentsencyclopedia.com/app/20220280472
sialidase in multiple human lung cell types that participate in IPF pathophysiology, including airway epithelia, microvascular endothelia
https://www.patentsencyclopedia.com/app/20220281949
acid residue 118 of SEQ ID NO: 1, (ii) an amino acid other than lysine at a position
https://www.patentsencyclopedia.com/app/20220280430
Lysine Salt; Treprostinil Diisobutyrate L-Lysine Salt; Treprostinil Dipivalate L-Lysine Salt; Treprostinil Methyl Dicarbonate L-Lysine Salt; Treprostinil Ethyl Dicarbonate
https://www.patentsencyclopedia.com/app/20220280654
as poly(lysine) and poly(valine) and mixed-sequence polypeptides; synthetic polymers including poly(ethylene glycol) (PEG
https://www.patentsencyclopedia.com/app/20080262390
polycaprolactone, polymers under clinical investigation including polyorthoester, polyanhydrides, and polyhydroxyalkanoate, early stage polymeric biomaterials including poly(lactic acid-co
https://www.patentsencyclopedia.com/app/20080262543
polycaprolactone, polymers under clinical investigation including polyorthoester, polyanhydrides, and polyhydroxyalkanoate, early stage polymeric biomaterials including poly(lactic acid-co
https://www.patentsencyclopedia.com/hgl/09-08-22/09-08-22_9
a patient includes the sequential steps of: providing an immunogenic composition including an immunogen; adding a
https://www.patentsencyclopedia.com/app/20220280616
conjugation strategies used in these pegylated HBOCs are through random pegylation of lysine, thiolated lysine, cysteine or
https://www.patentsencyclopedia.com/app/20080262524
polycaprolactone, polymers under clinical investigation including polyorthoester, polyanhydrides, and polyhydroxyalkanoate, early stage polymeric biomaterials including poly(lactic acid-co
https://www.patentsencyclopedia.com/app/20220281954
of animal, boiling fish scales, etc.). [0007] Gelatin is used in many products including cosmetics, foods, pharmaceuticals, medical
https://www.patentsencyclopedia.com/app/20220296574
and neuroendocrine prostate cancer cells. The experiments utilized multiple clinically acceptable cell models, including (i) VCaP cells, which
https://www.patentsencyclopedia.com/app/20220296863
of a hydrophobic therapeutic agent and a combination of additives including a first
https://www.patentsencyclopedia.com/app/20220280629
linker that couples to reactive amino groups (e.g., --NH.sub.2 as found on lysine residues) on the
https://www.patentsencyclopedia.com/app/20220281854
the PRC2 complex which catalyzes the mono-through tri-methylation of lysine 27 on histone H3
https://www.patentsencyclopedia.com/app/20220296553
compositions as pharmaceutically active agents to, inter alia, treat disease in animals, including humans. Claims: 1. A
https://www.patentsencyclopedia.com/app/20220280522
more branched monomer units selected from the group consisting of a lysine moiety, an arginine moiety
https://www.patentsencyclopedia.com/app/20220280624
of pharmaceutical carriers include buffers such as phosphate, citrate, and other organic acids; antioxidants including ascorbic acid; low molecular
https://www.patentsencyclopedia.com/app/20220280509
a combination thereof. BACKGROUND OF THE INVENTION [0003] The site specific lysine methylation on histones is
https://www.patentsencyclopedia.com/app/20220280482
depression (including post partum depression, major depressive disorder and treatment-resistant depression), headache disorder (including cluster headaches and
https://www.patentsencyclopedia.com/app/20220233655
disease. In particular, in people suffering from Batten disease, lipofuscin accumulates inside cells, including those of the
https://www.patentsencyclopedia.com/app/20220233711
1-yloxy)carbonyl)-L-lysine, N -. epsilon.-(2-(Cyclooct-2-yn-1-yloxy)ethyl) carbonyl-L-lysine, and genetically
https://www.patentsencyclopedia.com/app/20220296505
the disclosure of which is incorporated herein by reference in its entirety, including all figures, tables and
https://www.patentsencyclopedia.com/app/20220233726
cancer. [0003] The common radiolabeled PSMA-targeting endoradiotherapeutic agents are derivatives of lysine-urea-glutamate (Lys-urea
https://www.patentsencyclopedia.com/app/20220233531
and it has the potential to improve outcomes in NSCLC, including patients with negative PD
https://www.patentsencyclopedia.com/app/20220283163
breast cancer; colorectal cancer; kidney cancer; esophageal cancer; lung cancer; skin cancer; ovarium cancer; uterine cancer, including endometrial cancer and
https://www.patentsencyclopedia.com/app/20220299505
detecting a target substance in a specimen, the chemical sensor including a sensitive
https://www.patentsencyclopedia.com/asnl/ap
OF LOCATION-BASED PROCESS EXECUTION 1 APIT LABORATORIES GMBH 2010-10-07 / 20100254963 - PEG-MODIFIED ARGININE/LYSINE OXIDOREDUCTASE 1 Apitope International
https://www.patentsencyclopedia.com/app/20220280632
of CIS43 VLP conjugation. A 19-amino acid peptide (SEQ ID NO:4) including the CIS43
https://www.patentsencyclopedia.com/inventor/sugai-jp-5/
MONOXIDE REDUCING AGENT - A smoking article includes a carbon monoxide reducing agent including particles including a
https://www.patentsencyclopedia.com/hgl/07-28-22/07-28-22_10
are useful as immunomodulatory molecules for the treatment of immune disorders including autoimmune diseases, such as
https://www.patentsencyclopedia.com/app/20220280470
is a bond, or alanine, cysteine, aspartic acid, glutamic acid, phenylalanine, glycine, histidine, isoleucine, lysine, leucine, methionine, asparagine, proline
https://www.patentsencyclopedia.com/app/20220298451
to a perfumed composition that is a mixture of fragrance compounds including for example
https://www.patentsencyclopedia.com/app/20220236273
protein may be genetically engineered to comprise a plurality of lysine residues. Such lysine residues
https://www.patentsencyclopedia.com/asnl/da
COLUMN REPAIR KIT 1 DADDY FOR BEBE CO.,LTD. 2021-06-17 / 20210177674 - DIAPER INCLUDING REMOVABLE WAISTBAND 1 DADE
https://www.patentsencyclopedia.com/app/20220281915
entity and the linker entity comprises palmitic acid -. gamma.-glutamic acid, palmitic acid-lysine, palmitic acid -. gamma.-glutamic
https://www.patentsencyclopedia.com/app/20220296530
in their entirety. In case of conflict, the present specification, including definitions, will control. [0031
https://www.patentsencyclopedia.com/app/20220298455
n-th part of an n-valent cation, the alkali metal ions, including Na.sup.+ or K
https://www.patentsencyclopedia.com/app/20220233456
of stimulants have been documented in a variety of areas including behavioral, social, perceptual performance
https://www.patentsencyclopedia.com/app/20220280526
not fully understood, however certain risk factors favor the development of psoriasis, including genetic predisposition, chronic infections
https://www.patentsencyclopedia.com/app/20220299522
carcinoma antigen by finding its expression in 10-90% of solid tumors including lung, prostate, breast, colon
https://www.patentsencyclopedia.com/inventor/erik-schulze-zur-wiesche-...
with a six-amino acid mixture consisting of taurine, proline, valine, arginine, lysine, and glycine
https://www.patentsencyclopedia.com/app/20220299521
of sensitivity booster is for peptide detection in proteins, protein bioconjugates, antibodies including monoclonal antibody (mAb), and
https://www.patentsencyclopedia.com/asnl/am
PERSONNEL RECRUTMENT SYSTEM USING FUZZY CRITERIA 1 Amazing Mazes, LLC 2008-08-28 / 20080205046 - Mirror Maze Including Floor Lighting 1 AMAZING
https://www.patentsencyclopedia.com/app/20220233504
not only the specified molecular entity but also its pharmaceutically acceptable, pharmacologically active analogs, including, but not limited to
https://www.patentsencyclopedia.com/app/20220233508
not only the specified molecular entity but also its pharmaceutically acceptable, pharmacologically active analogs, including, but not limited to
https://www.patentsencyclopedia.com/hgl/09-08-22/09-08-22_10
a photocatalyst film including the photocatalyst, and an air purification device including the photocatalyst
https://www.patentsencyclopedia.com/app/20220235391
the incorporated literature, patents, and similar materials differs from or contradicts this application, including but not limited to
https://www.patentsencyclopedia.com/hgl/09-01-22/09-01-22_10
for use in the treatment of various diseases or disorders, including use as an anti
https://www.patentsencyclopedia.com/app/20220280576
weight of lysine; for example about 7% by weight of lysine which greatly improves the
https://www.patentsencyclopedia.com/app/20220280537
claim 1, wherein the buffering agent is a Tris, a lysine, an arginine, an ethylenediamine
https://www.patentsencyclopedia.com/app/20220233506
Class name: Publication date: 2022-07-28 Patent application number: 20220233506 Abstract: Described herein are formulations including pharmaceutical agents comprising ester
https://www.patentsencyclopedia.com/app/20220235390
of the reaction solution after reaction is completed) of multiple fluorescent proteins (including 19 proteins, for
https://www.patentsencyclopedia.com/app/20220233715
threonine (T) at position 251 is mutated to alanine (A), and lysine (K) at position 534
https://www.patentsencyclopedia.com/app/20220235061
not substituted with hydroxyl. [0078] "Alkyl" refers to a saturated aliphatic hydrocarbon group, including linear chain and
https://www.patentsencyclopedia.com/app/20220280530
useful for prevention and treatment of neurological disorders or neurodegenerative diseases, including Alzheimer's disease, multiple
https://www.patentsencyclopedia.com/app/20220282276
acid to a subject's target cells can be carried-out by various methods, including the use
https://www.patentsencyclopedia.com/app/20220280573
collagen gel and hUC membrane extract polymerization as discussed in Example 2, including a 30
https://www.patentsencyclopedia.com/app/20220235105
of using the products and compositions to detect SUMO proteins, including SUMO conjugates, and
https://www.patentsencyclopedia.com/app/20220280539
from the group consisting of glycine, 1-arginine, phenylalanine, histidine, acetylcysteine, citrulline, lysine, isoleucine, methionine, cysteine and
https://www.patentsencyclopedia.com/app/20220281833
Post-translational modification of proteins through acetylation and deacetylation of lysine residues plays a
https://www.patentsencyclopedia.com/app/20220232869
of isolated steviol glycosides has been limited to date by certain undesirable taste properties, including licorice taste, bitterness, astringency
https://www.patentsencyclopedia.com/app/20220282112
for the polyisocyanate compound include organic polyisocyanates, such as aliphatic diisocyanate compounds such as lysine diisocyanate, hexamethylene diisocyanate and
https://www.patentsencyclopedia.com/app/20220280510
FOXO1 or t(1; 13)(p36; q14) which fuses PAX7 and FOXO1. Epigenetic regulation, including post-translational modifications of
https://www.patentsencyclopedia.com/app/20220281920
interaction between the A ring (in green) and NEMO including the insertion
https://www.patentsencyclopedia.com/app/20220281999
the peptides of the present disclosure are capable of separating cells (including microorganisms and biofilms
https://www.patentsencyclopedia.com/app/20220280481
used for plaque psoriasis. Antagonists of CCR6 and/or CXCR2 including the compounds
https://www.patentsencyclopedia.com/app/20220281872
and use thereof. BACKGROUND [0002] Epigenetic alterations play an important role in cell evolution (including cell proliferation, cell differentiation
https://www.patentsencyclopedia.com/app/20220235100
absorbing and quick-drying properties to an article, the method including a step
https://www.patentsencyclopedia.com/app/20220280438
with the virus stock solution in saline, sucrose, dextrose, and lysine-dextrose solution, respectively) and
https://www.patentsencyclopedia.com/app/20220233686
Thus, it has been described that cocktails of defined epitopes or chimeric protein arrangements including the target
https://www.patentsencyclopedia.com/app/20220280463
tartrate, benzoate, lactate, histidine or other amino acids such as arginine, alanine, glycine and lysine, gluconate, phosphate, malate, succinate
https://www.patentsencyclopedia.com/app/20220280523
PKs) are a group of enzymes that regulate diverse, important biological processes including cell growth, survival and
https://www.patentsencyclopedia.com/app/20220233690
systemic inflammatory response that can be triggered by a variety of factors, including certain drugs. When the
https://www.patentsencyclopedia.com/inventor/then-us-5/
Then, US Alan Then, Plano, TX US Patent application number Description Published 20140320857 COLOR MEASUREMENT SYSTEM INCLUDING LATERAL MOVING MEASURMENT CARRAIGE
https://www.patentsencyclopedia.com/app/20220281918
piperazine, benzylamine, phenylbenzylamine, choline, meglumine, and tromethamine, as well as amino acids, such as lysine and arginine
https://www.patentsencyclopedia.com/inventor/kozlov-ru-5/
Method of processing an e-mail to determine a categorization thereof including a sender
https://www.patentsencyclopedia.com/app/20220281922
and screened. A variety of capsid engineering methods have been used, including DNA barcoding, directed evolution
https://www.patentsencyclopedia.com/app/20220296559
inhibitor. The particles are delivered to the patient's pulmonary system, including the upper
https://www.patentsencyclopedia.com/app/20220233490
of the present invention. [0034] All publications cited herein are hereby incorporated by reference including all journal articles, books
https://www.patentsencyclopedia.com/app/20220282235
to catalyze the hydrolysis of a variety of polymers, including polyesters. In this
https://www.patentsencyclopedia.com/app/20220282232
to catalyze the hydrolysis of a variety of polymers, including polyesters. In this
https://www.patentsencyclopedia.com/app/20220296544
nm in diameter, which are associated with benign and malignant epithelial lesions, including >95% of cervical
https://www.patentsencyclopedia.com/app/20220237681
consume. Nutritional optimization while grocery shopping can improve the use of resources including time and money